Sep 07, 2023 / 02:15PM GMT
Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate Analyst
Welcome, everybody. Wells Fargo Healthcare Conference 2023 day 2. My name is Tim Daley. I'm life science tools, diagnostics and pharma services analyst. We are pleased to have here Neogen with Dave Naemura, CFO. And again, thanks for coming. We're going to, I guess, kick things off. This morning, you guys filed an 8-K, laid out some, I guess, more refined expectations around the first quarter. Just if you could kind of run us through what the update was, how that compares to, I guess, how you kind of previously talked about the first quarter. That will be great.
Questions and Answers:
David H. Naemura - Neogen Corporation - CFOYes. Sure, Tim. Thanks. I'm happy to be here. Obviously, we just ended the quarter. So our timing being a [May] year-end is a little bit tricky. So we ended the quarter last Friday before the holiday weekend, but got a view of the top line, which came in a little bit lighter than we had thought, but directionally I would say, in the same shape
Trustpilot
